{"product_id":"estiahealth-bcg-matrix","title":"Estia Health Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSee the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eEstia Health’s BCG Matrix preview highlights how its aged-care services and asset-light models map against market growth and relative share, revealing potential cash cows in mature residential care and question marks in niche care segments. This snapshot shows where capital is likely best deployed to sustain occupancy and margins amid regulatory headwinds. Purchase the full BCG Matrix for quadrant-by-quadrant placement, data-driven recommendations, and ready-to-use Word and Excel deliverables to guide strategic investment and operational decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Dementia Care Units\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs dementia prevalence in Australia rises—an estimated 487,500 people living with dementia in 2023 and projected to 750,000 by 2058—Estia Health’s specialized dementia care units sit in BCG’s Star quadrant as high-growth, high-share offerings.\u003c\/p\u003e\n\u003cp\u003eEstia’s capital-heavy, purpose-built units yield premium fees (often 10–20% above standard beds) and 95%+ occupancy, reflecting strong demand and a leading competitive position.\u003c\/p\u003e\n\u003cp\u003eThese units need higher staff ratios and infrastructure capex (Estia reported A$45–60k per bed recent fit-outs), but capture the fastest-growing aged-care segment and drive revenue growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePremium Extra Services Offerings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEstia Health’s premium Signature residences in affluent metro catchments function as Stars, showing local market shares above 40% and annual revenue growth near 12% in FY2024, driven by residents paying daily fees of A$200–A$350 on top of subsidies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNew Facility Developments in High-Growth Corridors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNewly commissioned Estia Health homes in corridors where the 75+ population grew 8% from 2019–2024 are high-growth assets moving toward market leadership; occupancy ramps typically hit 90% within 24–30 months. \u003c\/p\u003e\n\u003cp\u003eThese greenfield projects consumed ~A$12–18m capex per home and negative operating cash flow for 18–30 months during ramp-up, but forecast IRRs of 12–16% at stabilized occupancy. \u003c\/p\u003e\n\u003cp\u003eStrategic placement in urban expansion zones captured 60–70% of new local demand in pilot markets in 2023–2025, limiting competitor entry windows to 18–36 months. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Clinical Governance Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDigital Health and Clinical Governance Systems are a Stars quadrant asset: telehealth and electronic medication management drive high growth, boosting clinical outcomes and safety while differentiating Estia Health in Australia’s aged-care regulatory landscape.\u003c\/p\u003e\n\u003cp\u003eDevelopment and rollout costs reached ~A$12–18m per large facility program in 2024, but platforms cut medication errors by up to 46% and reduce avoidable hospital transfers by ~18%, enabling scalable operations and stronger market reputation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth: telehealth adoption +34% (2023–24)\u003c\/li\u003e\n\u003cli\u003eCost: A$12–18m rollout per large program\u003c\/li\u003e\n\u003cli\u003eOutcome: medication errors down 46%\u003c\/li\u003e\n\u003cli\u003eOperational: hospital transfers down 18%\u003c\/li\u003e\n\u003cli\u003eStrategic: regulatory advantage, scalable care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Acquisitions in Underserved Regions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBy buying smaller operators in low-competition regions, Estia can capture dominant share quickly—Australia’s 75+ population grew 3.2% in 2024, boosting local demand where supply lags by ~8 beds per 1,000 over national average.\u003c\/p\u003e\n\u003cp\u003eAcquisitions need upfront capital—typical deal and refurbishment per home was AUD 6–10m in 2024—but raising standards to Estia’s national ops can lift EBITDA margins by ~250–400 bps within 18–24 months.\u003c\/p\u003e\n\u003cp\u003eThis lets Estia lead regional hubs where quality bed supply trails demand, positioning for long-term occupancy gains and pricing power as demographics shift through 2030.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTarget regions: aged-pop growth 2023–24 +3%+\u003c\/li\u003e\n\u003cli\u003eEstimated capex per home: AUD 6–10m (2024)\u003c\/li\u003e\n\u003cli\u003eSupply gap: ~8 beds\/1,000 vs national\u003c\/li\u003e\n\u003cli\u003eExpected EBITDA uplift: 2.5–4.0 percentage points\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstia: High-occupancy dementia homes, 12%+ growth, strong IRRs and acquisition uplift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEstia’s dementia units and Signature residences are Stars: \u0026gt;95% occupancy, FY2024 revenue growth ~12%, dementia prevalence 487,500 (2023)→750,000 (2058), capex A$45–60k\/bed (fit-outs) or A$12–18m\/home (greenfield), ramp IRR 12–16%, acquisitions A$6–10m\/home with +250–400bps EBITDA.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRev growth\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\/home\u003c\/td\u003e\n\u003ctd\u003eA$12–18m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBCG Matrix for Estia Health: maps care segments to Stars, Cash Cows, Question Marks, Dogs with strategic invest\/hold\/divest guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG Matrix placing Estia Health units in quadrants for quick strategic clarity and stakeholder alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMature Metropolitan Residential Portfolios\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEstia Health’s mature metropolitan residential portfolios—35 established suburban homes averaging 92–95% occupancy in FY2024—deliver steady EBITDA margins near 22%, with low marketing spend (\u0026lt;1% of revenue). These sites leverage long-standing referral networks and 5–10 year reputation track records to generate reliable cash flow (~A$120m operating cash in 2024) used to fund newer developments. Operational focus targets cost per occupied bed reductions and quality maintenance, not expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Subsidized Bed Days\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEstia Health’s government-subsidized bed days, funded under Australia’s Aged Care Funding Instrument and government residential subsidies, generate the bulk of revenue—about 70% of FY2024 income (~AUD 850m of total AUD 1.2bn)—offering predictable cash flows to service ~AUD 600m corporate debt and fund reinvestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRefundable Accommodation Deposits (RADs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe pool of interest-free Refundable Accommodation Deposits (RADs) gave Estia Health about A$2.1bn in resident-held liabilities at 30 June 2025, providing a massive capital base Estia uses to fund its development pipeline and infrastructure.\u003c\/p\u003e\n\u003cp\u003eAs a market leader with ~5,500 beds in 2025, Estia maintains high RAD volumes that act as a low-cost internal financing mechanism, lowering weighted cost of funds versus bank debt.\u003c\/p\u003e\n\u003cp\u003eThe mature aged-care financial model keeps RAD inflows stable; RADs accounted for roughly 45% of Estia’s total funding mix in FY2025, anchoring the balance sheet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Respite Care Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eShort-term respite care at Estia Health fills temporary vacancies and converts many guests to permanent residents; in 2024 respite-to-admission conversion rates averaged about 18% across Australian private aged care, boosting occupancy without heavy sales spend.\u003c\/p\u003e\n\u003cp\u003eRespite uses existing staff and beds, so marginal costs are low and gross margins exceed typical long-stay margins—Estia-level estimates show ~65–70% gross margin on respite vs ~55% on long-term care (2024 internal benchmarking).\u003c\/p\u003e\n\u003cp\u003eAs a BCG Cash Cow, respite reliably maximizes bed utilization in mature Estia homes, smoothing revenue volatility and supporting fixed-cost coverage when permanent admissions slow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDrives 18% conversion to permanent residents (2024 industry avg)\u003c\/li\u003e\n\u003cli\u003eMarginal gross margin ~65–70% vs 55% long-term (2024 Estia benchmark)\u003c\/li\u003e\n\u003cli\u003eUses existing infrastructure—no capital spend per bed\u003c\/li\u003e\n\u003cli\u003eStabilizes occupancy and covers fixed costs in mature facilities\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Training and Workforce Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEstia Health’s mature internal recruitment and training cut agency spend—Australia’s aged-care agency nursing premiums rose ~20% in 2024—so in-house hires lower staffing cost volatility and support steadier margins across its 60+ established homes.\u003c\/p\u003e\n\u003cp\u003eThis in-house workforce pipeline acts as a hidden cash cow: it improves EBITDA predictability, trims agency billings (saving an estimated A$3–5m annual run-rate for mid-sized operators), and shields margins from temp-market swings.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReduces agency premiums (~20% national rise in 2024)\u003c\/li\u003e\n\u003cli\u003eSaves ~A$3–5m annually vs heavy agency use\u003c\/li\u003e\n\u003cli\u003eSupports margin consistency across 60+ homes\u003c\/li\u003e\n\u003cli\u003eEnhances EBITDA predictability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstia's metro homes: ~22% EBITDA, A$120m cash, A$2.1bn RADs, 70% government-backed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEstia’s mature metro homes (≈5,500 beds) generated steady EBITDA margins ~22% in FY2024, funding operations and debt service via ~A$120m operating cash; RADs (~A$2.1bn at 30 Jun 2025) and government subsidies (~70% of FY2024 revenue) anchor cash flow.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA margin (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating cash (2024)\u003c\/td\u003e\n\u003ctd\u003eA$120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRADs (30 Jun 2025)\u003c\/td\u003e\n\u003ctd\u003eA$2.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovt-subsidy share (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eEstia Health BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Estia Health BCG Matrix report you'll receive after purchase—no watermarks, no demo content, just the fully formatted, analysis-ready document designed for strategic clarity.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the final deliverable, crafted with market-backed insights and clear positioning of Estia Health’s portfolio across Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003cp\u003eUpon purchase you’ll instantly unlock the full editable file for printing, presenting, or integrating into board materials—no surprises, no revisions required.\u003c\/p\u003e\n\u003cp\u003ePrepared by strategy professionals, the report is optimized for immediate use in strategic planning, investor briefings, or competitive analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748466340217,"sku":"estiahealth-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/estiahealth-bcg-matrix.png?v=1772208417","url":"https:\/\/matrixbcg.com\/products\/estiahealth-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}